Aperio Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $317K | Buy |
42,614
+1,606
| +4% | +$11.9K | ﹤0.01% | 2163 |
|
|
2020
Q3 | $141K | Sell |
41,008
-3,220
| -7% | -$11.1K | ﹤0.01% | 2281 |
|
|
2020
Q2 | $211K | Buy |
44,228
+26,356
| +147% | +$126K | ﹤0.01% | 2163 |
|
|
2020
Q1 | $36K | Buy |
17,872
+13
| +0.1% | +$26 | ﹤0.01% | 2288 |
|
|
2019
Q4 | $62K | Sell |
17,859
-17,687
| -50% | -$61.4K | ﹤0.01% | 2290 |
|
|
2019
Q3 | $102K | Buy |
35,546
+19,381
| +120% | +$55.6K | ﹤0.01% | 2239 |
|
|
2019
Q2 | $61K | Sell |
16,165
-4,938
| -23% | -$18.6K | ﹤0.01% | 2492 |
|
|
2019
Q1 | $172K | Buy |
21,103
+9,750
| +86% | +$79.5K | ﹤0.01% | 2188 |
|
|
2018
Q4 | $92K | Buy |
+11,353
| New | +$92K | ﹤0.01% | 2233 |
|